SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > June 2015

« Previous month Next month »

Sequenom case leaves pharma confused over patent law

30-Jun-2015 - US intellectual property (IP) rules and a string of recent court cases are reducing the types of inventions pharma companies can patent, and “calling into question entire portfolios,” says a...

Juniper to make OxSonics' ultrasound particles to aid cancer drug delivery

30-Jun-2015 - Juniper Pharma Services has won a contract to manufacture ‘sono-sensitive particles’ used to aid delivery of cancer drugs into solid tumours for OxSonics.

'Outperform' Perrigo better off without Mylan, says analyst report

30-Jun-2015 - The proposed Perrigo merger with Mylan would be of no benefit to either firm in the “highly competitive” OTC sector, according to financial analysts BMO.

ICH clarifies Q7 guidance on API GMP manufacturing

30-Jun-2015 - In response to a flood of requests over uncertainties regarding ICH Q7 guidance, the international consortium recently released a question and answer  (Q&A) document intended help companies implement appropriate GMPs (good manufacturing...

Teva pays $35m upfront for implantable drug delivery device partnership

30-Jun-2015 - Generic juggernaut Teva Pharmaceuticals has partnered with Microchips Biotech to use its implantable drug delivery device to improve outcomes for patients on chronic drug therapies.

Chin up: Allergan looks to fat-busting drug with $2.1bn Kythera deal

29-Jun-2015 - Allergan is set to acquire Kythera Biopharmaceuticals for $2.1bn (€1.9bn) and add the recently approved injectable ‘double-chin’ drug Kybella to its facial aesthetics portfolio.

Health Canada asks importers to quarantine Polydrug APIs over data concerns

29-Jun-2015 - Canada has asked importers to quarantine APIs made by India’s Polydrug Laboratories over concerns about its manufacturing plant in Ambarnath in Maharashtra.

Trial data: charity hits back at CRO’s anti-transparency bid

25-Jun-2015 - Charity Sense About Science is attempting to intervene in a UK CRO’s legal action against trial transparency.

Saneca buys Europe's only independent, US FDA approved Beta-lactams plant

25-Jun-2015 - API firm Saneca Pharmaceuticals has acquired struggling drug formulator Suir Pharma Ireland in a deal with former owner Mutares AG.

News in brief

Thermo Fisher will pay £256m for Alfa Aesar

25-Jun-2015 - Thermo Fisher Scientific has anncouned plans to buy research chemicals firm Alfa Aesar from Johnson Matthey for £256m ($405m).

UK scientists discover key poppy alkaloid production enzyme

25-Jun-2015 - GSK and UK academics claim a newly identified enzyme is the missing link in the mechanism poppies use to make painkilling alkaloids like morphine and codeine and the anticancer compound...

‘Record-breaking’ 2015 will see surge in pharma acquisitions

25-Jun-2015 - Demand for CNS assets will help break records for pharma M&As in 2015, Neel Patel, VP of inVentiv Health consultancy Campbell Alliance, tells in-Pharmatechnologist.com. 

US FDA publishes API-salt naming policy

24-Jun-2015 - Naming drugs using active pharmaceutical ingredients (API) rather than their salts will cut down on medication and dosing errors according to the US Food and Drug Administration (FDA).

Small-scale will be the next big thing says UK’s CPI

24-Jun-2015 - Small-scale production techs will dominate biopharma says the UK organisation tasked with developing the £20m “biologics factory of the future” and the £38m National Biologics Manufacturing Centre in Darlington.

US FDA & INTERPOL seize fake meds from 1,000 websites

24-Jun-2015 - The US FDA has seized illegal medicines and medical devices sold by more than 1,050 websites.

BIO 2015

TTIP trade talks will 'force' FDA-EMA to sync regs, says biopharma

23-Jun-2015 - Eli Lilly’s President of Biomedicines says the transatlantic trade agreement TTIP will “force” the FDA and EMA to standardise regulations on manufacturing and trials.

US FDA: Generic pills must look similar to reference drugs to minimize patient safety risk

23-Jun-2015 - Generic pills are a safety risk if they are too different from their reference drug according to the US FDA, which wants developers to consider physical characteristics when making copycat...

BIO 2015

Does second prequalified vaccine mark China as ‘true global player’?

23-Jun-2015 - China is set to become a major vaccines manufacturer for emerging markets once it untangles some regulatory quirks, says a panel at BIO 2015. 

EU pharma industry a step closer to fake fighting drug repository

23-Jun-2015 - Industry efforts set up a drug database to help Europeans identify fake pharmaceuticals progressed this week after thee software firms signed development deals with project leader, EMVO.

News in brief

Dutch pharma policy NGO Health Action International opens Brussels office

23-Jun-2015 - Health Action International (HAI) has set up an office in Brussels, Belgium in a bid to further influence European pharmaceutical policy and improve access to medicines and public health.

New nanotech excipient makes for better delayed-release drugs say researchers

22-Jun-2015 - Swedish scientists who developed the solubility enhancing nanotech excipient Upsalite say it can also be used to improve delayed release formulations.

South Korea mulls combining HIV drugs with antivirals to combat MERS

22-Jun-2015 - As the death toll from MERS in South Korea edged to two dozen scientists there say the outbreak is different from in Saudi Arabia and also from its the related...

ScinoPharm to make API for Chinese drugmaker eyeing US celecoxib market

22-Jun-2015 - Raffles PharmaTech has contracted ScinoPharm to make the API for a generic version of the arthritis pain drug celecoxib being developed for the US market.

Phos enzyme ID'd using CRISPR may lead to safer cancer meds say researchers

19-Jun-2015 - A newly identified enzyme that modifies secreted proteins could lead to safer cancer drugs and new osteoporosis treatments say scientists.

« Previous month Next month »

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...